Webinar: Generating Fully Human Antibodies and Antibody-based Therapeutics with RenMab, RenLite & RenNano Mice

  Our webinar “Generating Fully Human Antibodies and Antibody-based Therapeutics with RenMab, RenLite & RenNano Mice" will be live at 1:00 PM EDT on June 20th,…

Read more
Join us at PEGSBoston: May 15-19

Join us in our luncheon presentation and meet with our team at booth #9 in PEGS Boston from May 15-19 ! Learn more about our…

Read more
Join us at ASGCT2023: May 16-20

  Join us at booth #574 at American Society of Gene & Cell Therapy Annual Meeting 2023 from May 16-20 in Los Angeles, CA! Learn…

Read more
Meet Biocytogen’s Business Development Team at BIO KOREA 2023!

Biocytogen’s business development team is pleased to exhibit and host 1-on-1 meetings at BIO KOREA 2023, taking place from May 10-12, 2023 in Seoul, South Korea. Join…

Read more
Webinar: Joint, Lung, and Urinary Disease Models Offered at Biocytogen

Our webinar “Joint, Lung, and Urinary Disease Models Offered at Biocytogen" was live at 1:00 PM EDT on May 25th, 2023.  About the Webinar Inflammatory disease…

Read more
Join us at Immunology 2023: May 11-15

Join us at booth #4097 at Immunology 2023 from May 11-15 in Washington. D.C! Learn more about our custom model generation services and other platforms…

Read more
AACR 2023 posters

We're attending AACR 2023, held from April 14-19 in Orlando, Florida! For the latest advances, service offerings, and promotions, register now to visit our team…

Read more
8th Annual Innate Killer Summit

Join us at the 8th Annual Innate Killer Summit in La Jolla, CA from March 28- 30! Our team of experts will be on site…

Read more
Biocytogen to Host 1-on-1 Meetings at BIO-EUROPE SPRING® 2023

Biocytogen’s antibody BD and licensing team is pleased to attend and host 1-on-1 meetings at the 17th annual BIO-Europe Spring, taking place March 20–22, 2023…

Read more
Festival of Biologics – USA

Join us at the The Festival of Biologics USA in San Diego, CA from March 20- 22! Learn more about our antibody discovery capabilities and…

Read more
Back to top